Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451996 · ClinicalTrials.gov registry record · Phase 4
The Efficacy of Claritin in Healthy Subjects
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 340
- Enrollment target
NCT01451996: Completed Phase 4 study, sponsored by University of Chicago.
NCT01451996 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 340 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01451996, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 340 participants
- Enrollment target
Study Summary
The primary goal of this study is to examine determinants of the efficacy of Claritin.
Primary Outcome
A research technician, blinded to the subject's condition, measured the extent of the skin inflammation at baseline and 2 hours post Claritin administration by tracing the wheal reaction after the histamine challenge (i.e. the slightly reddened, elevated area at the site of the challenge, a well-established measure of histamine response). The percentage change in the wheal reaction was calculated as the change (decrease) in the size relative to baseline, multiplied by 100. Wheal area was measure
Interventions
- DRUG Claritin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
What the finished NCT01451996 record still lists
NCT01451996 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 1 intervention - of which Claritin is the first listed.
NCT01451996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01451996 about?
NCT01451996 is a clinical study titled "The Efficacy of Claritin in Healthy Subjects". The primary goal of this study is to examine determinants of the efficacy of Claritin.
What is the current status of trial NCT01451996?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 340 participants. The study started on 2011-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01451996?
The interventions under investigation include: Claritin (DRUG).
Who is sponsoring clinical trial NCT01451996?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01451996's enrollment target sits among peer trials
340 246th of 2000 higher than 1,753 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia